Enlimomab [142864-19-5]

TargetMol Chemicals

Enlimomab

9

142864-19-5

Antibody

Research Use Only

Enlimomab

Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody targeting human ICAM-1, reduces leukocyte adhesion to the vascular endothelium, diminishing leukocyte extravasation and inflammatory tissue damage; it exhibits anti-inflammatory properties and is utilized in stroke research [1] [2].

3 years

-20°C

12352203